{"id":"NCT01462266","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)","officialTitle":"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01-13","primaryCompletion":"2013-06-06","completion":"2013-06-07","firstPosted":"2011-10-31","resultsPosted":"2014-04-08","lastUpdate":"2018-08-17"},"enrollment":660,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Sitagliptin","otherNames":["Januvia"]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Insulin Glargine","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":["Glucophage"]}],"arms":[{"label":"Sitagliptin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to examine the insulin-sparing effect of sitagliptin 100 mg once-daily compared with placebo over 24 weeks in participants with type 2 diabetes mellitus who have inadequate glycemic control on insulin alone or in combination with metformin. The primary hypothesis of this study is that after 24 weeks, sitagliptin reduces the dose of insulin relative to placebo.","primaryOutcome":{"measure":"Change From Baseline in Daily Insulin Dose at Week 24","timeFrame":"Baseline and Week 24","effectByArm":[{"arm":"Sitagliptin","deltaMin":19,"sd":19.6},{"arm":"Placebo","deltaMin":23.8,"sd":24}],"pValues":[{"comp":"OG000 vs OG001","p":"0.009"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":15},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["25820927"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":329},"commonTop":["Hypoglycaemia","Nasopharyngitis","Urinary tract infection","Diarrhoea"]}}